Tag: Glooko
In brief: VGM’s new collab, Kalogon’s funding, Medline’s milestone
June 5, 2026HME News Staff
WATERLOO, Iowa — VGM & Associates has launched a collaboration with Resmed to help home medical equipment (HME) providers strengthen their sleep therapy programs. By combining VGM’s expanding Total Sleep Services offering with Resmed’s connected sleep health capabilities, the two companies say they create a more connected path from diagnosis to long-term therapy adherence.
The collaboration brings together VGM’s member community and category expertise with Resmed’s...
Glooko, mylife Diabetes Care expand partnership, ensure continuity
June 3, 2026HME News Staff
GOTEHNBURG, Sweden and BURGDORF, Switzerland – As a result of an expanded partnership Glooko will serve as mylife Diabetes Care’s primary data management platform for mylife products. The companies say this next step ensures continuity in the way health care professionals and patients access data from mylife products, including mylife Loop, an automated insulin delivery (AID) solution powered by mylife CamAPS FX from CamDiab. They say it also strengthens the shared commitment of both...
Glooko integrates with Roche Accu-Chek CGM
March 11, 2026HME News Staff
GOTHENBURG, Sweden – Glooko has announced that the Glooko platform will integrate with the Roche Accu-Chek SmartGuide continuous glucose monitor (CGM) solution across select European countries, subject to local availability. The company says this integration will enable people using the Accu-Chek SmartGuide CGM to bring their data into Glooko, alongside data from other connected diabetes and health monitoring devices. It says this can reduce the administrative burden for health care teams,...
In brief: Invacare closure, NSM CEO, BOC honor
April 14, 2023HME News Staff
ELYRIA, Ohio – Invacare will close its production and distribution facility in Sanford, Fla., at the end of September 2023, in a move that will impact about 90 associates, according to a Form 8-K filed with the U.S. Securities and Exchange Commission.
The company will move the manufacturing and distribution activities that take place at the Sanford facility to other locations or have them conducted by third parties.
“This decision is supportive of the company’s...
Glooko partners with insulin-dosing platform
April 14, 2023HME News Staff
PALO ALTO, Calif. – Glooko, Inc. has entered into a partnership with Hedia, integrating its insulin dosing technology into Glooko’s diabetes management platforms for healthcare providers and people with diabetes. “We are very pleased to partner with Hedia to offer this algorithm-driven innovation for personalized healthcare for diabetes patients and their healthcare teams,” said Russ Johannesson, CEO of Glooko. “The robust clinical data supporting Hedia’s efficacy...
Glooko, Eli Lilly to collaborate on connected insulin pens
May 7, 2021HME News Staff
GOTHENBURG, Sweden – Glooko will partner with Eli Lilly for a strategic digital health collaboration using Eli Lilly’s connected insulin pens, the Tempo Pen and Tempo Smart Button. Through the agreement, the Tempo Smart Button will pair with Glooko’s software to integrate personalized health care data from the Tempo Pen, allowing it to be viewed and analyzed alongside other relevant data from other devices, fitness trackers and food logs. “Lilly is...
Crushing it? For the diabetes herd, technology is path forward
April 13, 2021Theresa Flaherty, Managing Editor
I got my first COVID vaccination in early April and immediately slacked my co-workers to share an image of my “Crushing COVD-19” sticker. Along with the obligatory congratulatory emojis, came the obligatory jokes about government chips and tracking.
As a person with diabetes, I’m used to tracking. I track my numbers, my insulin doses and my carbs. In turn, my Freestyle Libre sensor tracks me and sends data wirelessly to the Diabetes Center from my iPhone (no more arriving at...
Glooko raises stakes on remote monitoring
April 2, 2021Theresa Flaherty, Managing Editor
PALO ALTO, Calif. – Glooko saw its remote monitoring business take off in 2020 and plans to use recent funding to increase adoption of its platform by diabetes patients and their health care providers.
The company, which provides a software-as-a-service application and accompanying mobile app, will ramp up its marketing, among other efforts, after raising $30 million in Series D funding.
“Remote monitoring is a solution we’ve...
In brief: Oxygen adjustment, in-person visits, PromptCare sale, Glooko’s raise
March 19, 2021HME News Staff
WASHINGTON – CMS has published an adjusted fee schedule for oxygen therapy for April 2021 that no longer includes a percentage reduction to meet the budget neutrality requirement.
The adjustments result in an increase in fee schedule amounts ranging from $6.72 to $8.19 in former competitive bidding areas; $5.17 to $5.43 in other non-rural areas; and $4.14 to $6.82 in non-contiguous and rural areas, according to the VGM Group.
The fee schedule amounts are not retroactive...
Glooko raises $30M to accelerate growth
March 17, 2021HME News Staff
PALO ALTO, Calif. – Glooko, a provider of remote patient monitoring and chronic care management solutions including diabetes and obesity, has raised a $30 million Series D round of funding.
The company will use proceeds from the funding to accelerate organic growth and strategic initiatives across its product line of digital health solutions, including increasing adoption of is remote patient monitoring platform, widening commercialization of products...